1. VIth International Symposium on 
Hypertension and Renal Disease in the Diabetic Patient

Dead Sea, Israel, September 21-22, 2000

Second Announcement and Preliminary Program

Welcome
Note

Preliminary
Program

Registration

General
Information

Hotel
Accommodation

Registration and Accommodation Form

 

Post Symposium Tours

THURSDAY, SEPTEMBER 21, 2000
OPENING SESSION 18:20 - 20:00
  Chairperson: I. Raz, Israel  
18:20 OPENING REMARKS 1001
G. Boner, Israel
 
18:30 DIABETES MELLITUS AND HYPERTENSION AS MAJOR RISK FACTORS
FOR THE DEVELOPMENT OF CARDIAC AND RENAL DISEASE
J. Yudkin, UK
 
19:15 IS THERE A GENETIC PREDISPOSITION TO THE DEVELOPMENT OF RENAL DISEASE IN DIABETIC PATIENTS?
M. Marre, France
 
20:00 WELCOME RECEPTION  
FRIDAY, SEPTEMBER 22, 2000
SESSION I: 08:30 - 09:45
  Chairperson: D.J. Van Dijk, Israel  
08:30 GROWTH FACTORS IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY 1008
I. Raz, Israel
 
08:55 THE RENIN-ANGIOTENSIN SYSTEM IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY 1031
S. Anderson, USA
 
09:20 ENDOTHELIAL DYSFUNCTION: ITS ROLE IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY
T.J. Rabelink, The Netherlands
 
SESSION II: ADVANCED GLYCOSYLATION END PRODUCTS (AGES) IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY  09:45 - 10:25
09:45 RESTORING CARDIOVASCULAR COMPLIANCE IN DIABETIC AND AGING
ANIMAL MODELS: BREAKING THE AGE CROSSLINK
J. Egan, USA
 
10:05 AGES AND DIABETIC NEPHROPATHY AND THERAPEUTIC POSSIBILITIES IN PREVENTION AND TREATMENT OF AGE DEPOSITION
M. Cooper, Australia
 
10:25 COFFEE BREAK 1012  
SESSION III: 10:45 - 12:40
  Chairperson: R. Viskoper, Israel  
10:45 HYPERTENSION AND CARDIOVASCULAR MORTALITY IN DIABETIC PATIENTS
H-H. Parving, Denmark
 
11:00 INNOVATIONS IN PATHOGENESIS OF HYPERTENSION IN DIABETICS
P.T. Sawicki, Germany
 
11:25 INNOVATIONS IN DIABETIC NEPHROPATHY
G-C. Viberti, UK
 
11:50 GLOMERULAR CELL NUMBERS IN TYPE 1 DIABETES MELLITUS: EFFECTS OF AGE, DURATION AND PANCREAS TRANSPLANTATION
M. Steffes, USA
 
12:15 ISLET CELL TRANSPLANTATION IN DIABETES MELLITUS - CURRENT ASPECTS AND PERSPECTIVES REGARDING PREVENTION OF RENAL DISEASE
R.G. Bretzel, Germany
 
12:40 LUNCH BREAK 1017  
SESSION IV:  13:40 - 14:10
  Chairperson: U. Gafter, Israel  
13:40 CRITICAL EVALUATION OF THE RECENT MAJOR TRIALS OF THE TREATMENT OF HYPERTENSION AND RENAL INVOLVEMENT IN DIABETICS
R. Gilbert, Australia
 
ROUND TABLE DISCUSSION:  14:10 - 15:10
  Chairperson: M. Ravid, Israel  
14:10 USE OF ACE INHIBITORS, AII RECEPTOR BLOCKERS AND CALCIUM CHANNEL BLOCKERS IN THE TREATMENT OF HYPERTENSION AND RENAL DISEASE IN DIABETIC PATIENTS  
15:10 COFFEE BREAK  
KIDNEY INTERNATIONAL NEPHROLOGY FORUM 15:30 - 17:00
15:30 PRESENTATION OF A PATIENT WITH DIABETIC RENAL DISEASE AND DISCUSSION OF ALL ASPECTS
H-H. Parving, Denmark
 
17:00 CONCLUDING REMARKS AND SUMMARY
G. Boner, Israel, M. Ravid, Israel